Our in vitro co-culture studies revealed evidence that CLL cells can preferentially activate TFH and that TFH expansion is associated with ability of activated CD4+ T cells to trigger CLL proliferation in vitro. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.